In terms of valuation, BioCryst Pharmaceuticals Inc’s market capitalization stands at $1.66 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback